NVAX (STOCKS)
Novavax Inc
$9.162500
+0.282500 (+3.18%)
Prev close: $8.880000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John C.s Jacobs
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,516.94M
- Employees
- 1,992
- P/E (TTM)
- -15.41
- P/B (TTM)
- -10.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $596.34M |
| Benefits Costs and Expenses | $682.52M |
| Cost Of Revenue | $89.62M |
| Costs And Expenses | $674.49M |
| Gross Profit | $506.72M |
| Operating Expenses | $584.87M |
| Selling, General, and Administrative Expenses | $138.17M |
| Depreciation and Amortization | $22.34M |
| Research and Development | $348.86M |
| Operating Income/Loss | -$78.15M |
| Income/Loss From Continuing Operations After Tax | -$87.84M |
| Income/Loss From Continuing Operations Before Tax | -$86.19M |
| Income Tax Expense/Benefit | $1.65M |
| Net Income/Loss | -$87.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$87.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$87.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.54 |
| Diluted Earnings Per Share | -$0.64 |
| Basic Average Shares | 487,828,000 |
| Diluted Average Shares | 507,752,000 |
| Assets | $1.04B |
| Current Assets | $850.82M |
| Inventory | $11.46M |
| Other Current Assets | $839.36M |
| Noncurrent Assets | $192.35M |
| Fixed Assets | $42.15M |
| Other Non-current Assets | $150.20M |
| Liabilities | $1.19B |
| Current Liabilities | $342.46M |
| Accounts Payable | $16.10M |
| Other Current Liabilities | $326.36M |
| Noncurrent Liabilities | $845.46M |
| Long-term Debt | $291.04M |
| Other Non-current Liabilities | $554.42M |
| Equity | -$144.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$144.76M |
| Liabilities And Equity | $1.04B |
| Net Cash Flow From Operating Activities | -$91.56M |
| Net Cash Flow From Operating Activities, Continuing | -$91.56M |
| Net Cash Flow From Investing Activities | -$33.31M |
| Net Cash Flow From Investing Activities, Continuing | -$33.31M |
| Net Cash Flow From Financing Activities | $72.47M |
| Net Cash Flow From Financing Activities, Continuing | $72.47M |
| Exchange Gains/Losses | $6.84M |
| Net Cash Flow | -$45.56M |
| Net Cash Flow, Continuing | -$52.39M |
| Comprehensive Income/Loss | -$94.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$94.52M |
| Other Comprehensive Income/Loss | -$94.52M |
| Other Comprehensive Income/Loss Attributable To Parent | -$6.68M |